Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-21

Clinical Trial Update: Efficacy of Photobiomodulation in the Rehabilitation of Olfactory Dysfunctions Induced by Long COVID-19 [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating photobiomodulation therapy to rehabilitate olfactory dysfunction (anosmia and ageusia) caused by long COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gaffree & Guinle Universitary Hospital | Conditions: Anosmia, Ageusia | NA | Status: RECRUITING